Cargando…
Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic
During the geological eras, some fungi, through adaptation and/or environmental/ecological pressure, interacted directly and indirectly with humans, through occasionally harmful interaction interdependent on the individual’s immunological condition. Infections caused by yeasts are underreported, sub...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695014/ https://www.ncbi.nlm.nih.gov/pubmed/36363816 http://dx.doi.org/10.3390/microorganisms10112223 |
_version_ | 1784837950645731328 |
---|---|
author | Corrêa-Junior, Dario de Andrade, Iara Bastos Alves, Vinicius Araújo, Glauber R. de S. Frases, Susana |
author_facet | Corrêa-Junior, Dario de Andrade, Iara Bastos Alves, Vinicius Araújo, Glauber R. de S. Frases, Susana |
author_sort | Corrêa-Junior, Dario |
collection | PubMed |
description | During the geological eras, some fungi, through adaptation and/or environmental/ecological pressure, interacted directly and indirectly with humans, through occasionally harmful interaction interdependent on the individual’s immunological condition. Infections caused by yeasts are underreported, subjugated, and underdiagnosed, and treatment is restricted to a few drugs, even after the significant progress of medicine and pharmacology. In the last centuries, antagonistically, there has been an exponential increase of immunocompromised individuals due to the use of immunosuppressive drugs such as corticosteroids, increased cases of transplants, chemotherapeutics, autoimmune diseases, neoplasms, and, more recently, coronavirus disease 2019 (COVID-19). This review aims to survey emerging and re-emerging yeast infections in the current clinical context. Currently, there is an immense clinical challenge for the rapid and correct diagnosis and treatment of systemic mycoses caused by yeasts due to the terrible increase in cases in the current context of COVID-19. |
format | Online Article Text |
id | pubmed-9695014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96950142022-11-26 Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic Corrêa-Junior, Dario de Andrade, Iara Bastos Alves, Vinicius Araújo, Glauber R. de S. Frases, Susana Microorganisms Review During the geological eras, some fungi, through adaptation and/or environmental/ecological pressure, interacted directly and indirectly with humans, through occasionally harmful interaction interdependent on the individual’s immunological condition. Infections caused by yeasts are underreported, subjugated, and underdiagnosed, and treatment is restricted to a few drugs, even after the significant progress of medicine and pharmacology. In the last centuries, antagonistically, there has been an exponential increase of immunocompromised individuals due to the use of immunosuppressive drugs such as corticosteroids, increased cases of transplants, chemotherapeutics, autoimmune diseases, neoplasms, and, more recently, coronavirus disease 2019 (COVID-19). This review aims to survey emerging and re-emerging yeast infections in the current clinical context. Currently, there is an immense clinical challenge for the rapid and correct diagnosis and treatment of systemic mycoses caused by yeasts due to the terrible increase in cases in the current context of COVID-19. MDPI 2022-11-10 /pmc/articles/PMC9695014/ /pubmed/36363816 http://dx.doi.org/10.3390/microorganisms10112223 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Corrêa-Junior, Dario de Andrade, Iara Bastos Alves, Vinicius Araújo, Glauber R. de S. Frases, Susana Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic |
title | Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic |
title_full | Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic |
title_fullStr | Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic |
title_full_unstemmed | Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic |
title_short | Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic |
title_sort | clinical challenges of emerging and re-emerging yeast infections in the context of the covid-19 pandemic |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695014/ https://www.ncbi.nlm.nih.gov/pubmed/36363816 http://dx.doi.org/10.3390/microorganisms10112223 |
work_keys_str_mv | AT correajuniordario clinicalchallengesofemergingandreemergingyeastinfectionsinthecontextofthecovid19pandemic AT deandradeiarabastos clinicalchallengesofemergingandreemergingyeastinfectionsinthecontextofthecovid19pandemic AT alvesvinicius clinicalchallengesofemergingandreemergingyeastinfectionsinthecontextofthecovid19pandemic AT araujoglauberrdes clinicalchallengesofemergingandreemergingyeastinfectionsinthecontextofthecovid19pandemic AT frasessusana clinicalchallengesofemergingandreemergingyeastinfectionsinthecontextofthecovid19pandemic |